Currently, BSX's 12-month EPS stands at $1.89, according to the most recent financial reports. Boston Scientific's earnings per share in 2024 was reported at $1.26, marking a rise from $1.08 in 2023. BSX recorded an EPS of $0.51 for the quarterly period ending on Sep 30, 2025.
In 2024, Boston Scientific's earnings per share was $1.26, a rise of 16.7% from $1.08 in 2023. The quarterly earnings per share for the period ending Sep 30, 2025, was $0.51, showing a 59.4% increase compared to the same quarter last year. The trailing twelve months EPS for BSX is $1.89 as of September 2025. Boston Scientific's full-year EPS for 2023 was $1.08, a 140% rise compared to the previous year.
Over the past 12 months, Boston Scientific has recorded an earnings per share growth rate of 59.4% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of 22.2% per year for the last 3 years. In the last five years, the company had an average annual EPS growth of -17.9%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| EW Edwards Lifesciences Corp | 11.85 | 202.2% | 42.5% | 33% |
| CNMD CONMED Corp | 12.48 | 104.3% | 26.1% | 33.5% |
| MDT Medtronic plc | 24.84 | 31% | -1.1% | 0.3% |
| TFX Teleflex Inc | 28.81 | -80.3% | -47.6% | -31.7% |
| MMSI Merit Medical Systems Inc | 43.34 | 26.2% | 34% | 83.3% |
| SYK Stryker Corp | 46.33 | -5.8% | 14.1% | 7.1% |
| BSX Boston Scientific Corp | 52.33 | 16.7% | 22.2% | -17.9% |
| ANGO Angiodynamics Inc | N/A | 81.9% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.